N
NRC Health (NRC)
NMS – Real Time Price. Currency in USD
19.19
+0.48 (2.57%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
19.19
+0.48 (2.57%)
At close: May 12, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.52 | 2.19 | 4.0 | |
| Quick ratio | 0.52 | 1.96 | 4.0 | |
| Debt to Equity | 5.78 | 1.16 | 2.0 | |
| Debt to Assets | 0.58 | 2.94 | 4.0 | |
| Interest coverage | 4.44 | -28.30 | 10 | |
| Weighted average score | 4.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 152M | 149M | 143M | 137M | 139M |
| Gross Profit | 89M | 87M | 80M | 77M | 77M |
| Operating Income | 47M | 40M | 35M | 23M | 20M |
| Net Income | 32M | 31M | 25M | 11M | 9M |
| EBITDA | 52M | 46M | 41M | 30M | 28M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | 1.0 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | N/A | N/A | 1.0 |
| Next year | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -1.1 | 83.76 | N/A | -11.74 | 3.3 |
| Y/Y | 3.73 | -46.61 | N/A | 46.07 | 4.0 |
| 3y average | -3.2 | -25.64 | N/A | -15.83 | 1.0 |
| 5y average | 0.77 | -18.27 | N/A | -14.26 | 1.3 |
| Weighted average score | 2.4 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 3.19 | 3.19 | 8.0 |
| Payout ratio | 30.57 | 30.57 | 5.0 |
| 5-year dividend growth rate | 17.98 | 17.98 | 10 |
| Years of dividend increase | 0.00 | 0.00 | 1.0 |
| Weighted average score | 6.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Total debt $78.0M significantly exceeds cash reserves ($2.5M), raising financial stability concerns
Total current liabilities $38.5M surpass Total current assets $20.0M, signaling liquidity issues
Debt-to-equity ratio (5.8) far exceeds the industry average, reflecting over-leverage
Interest coverage ratio (4x) indicates the company easily manages its debt payments
The company generates positive free cash flow $5.3M, supporting its financial health